Katrine Tholstrup Bech

[Elliot Tapper @ebtapper]

Income is associated with a higher rate of under-reporting of alcohol consumption

Important observation!

@Helle_schne

[Katrine Tholstrup Bech @Kat_Bech]

Big day today: my first international conference oral presentation!
I’ll be talking about PEth vs self-reported alcohol use in individuals at risk of steatotic liver disease.
Catch me in de Groote Room, Alcohol Session, at 17:00 (OS-030-YI).
Excited and ready!
#EASLCongress

[Katrine Tholstrup Bech @Kat_Bech]

@MajaThiele @Liver_Screen @FLASH_OUH Proud and honoured to be representing this amazing work!

[LiverScreen H2020 @Liver_Screen]

🎉Time to celebrate! 3⃣0⃣,0⃣0⃣0⃣ individuals from across different European countries have been included in the @LiverScreen project.

A HUGE thank you goes to all participating subjects, study physicians and nurses, coordinators and administrators from the Consortium.

[Katrine Tholstrup Bech @Kat_Bech]

For those missing out on today’s #EASLstudio at #EASLcongress I highly recommend watching it on demand if wanting to learn more about bridging the gap between MASLD and ALD.
Thank you for a nice session @MajaThiele @IsraelsenMads @PoseElisa Alexandre Louvet and Christophe Moreno

[LiverAim @LiverAim]

@MajaThiele shows the flowchart of the largest trial researchers and industries will perform in the field of liver diseases
@LiverAim KOM
#changingtheparadigm

@AleksanderKrag @salvatore_piano @JVLazarus @schattenbergJ @miquelsb2 @IHIEurope @EASLedu @EASLnews

[Katrine Tholstrup Bech @Kat_Bech]

Detecting silent liver fibrosis is like playing hide and seek. You must know you're in the game & who you're looking for. Randomly seeking behind broken glasses for someone not doing the "peek-a-boo" leads to failure. What are our possibilities? https://t.co/jbTR4cSnuK

[Ramon Bataller @rabataller]

This large study confirms that the use of FIB-4 for fibrosis screening leads to a high number of FALSE POSITIVE cases and unnecessary referrals.

Sequential use with other biomarkers (ie. ELF) minimizes this limitation.

https://t.co/Cg8XzAoDkK #livertwitter #medtwitter

[EASLnews @EASLnews]

Our partners @Liver_Screen are hosting a networking session at #EASLCongress!

🗣The faculty are looking forward to meet and discuss with you their work in liver fibrosis screening. Join us!

📅 Friday 23 June, 10:00 - 10:30
📌General Hepatology Track Hub

All information on https://t.co/Ma8WJAKiFp

@Helle_schne #LiverTwitter

[Katrine Tholstrup Bech @Kat_Bech]

@Camilla_Dalby @AleksanderKrag @MajaThiele @IsraelsenMads @Johanne_Kragh @Helle_schne @maria_fogt @peter19791979 @KHThorhauge @KatrinePLindvig @Emil_deleuran @NikolajTorp_ @Stine_Johansen_ Sure!

[Aleksander Krag @AleksanderKrag]

Festival of Research 2023 at @SUND_SDU

> 200 citizens vistited our @FLASH_OUH
LIVER booth 💪🙏

👉Awareness of liver health in our community⬆️
👉Impact of #alcohol #obesity #NASH

Inspired by @EASLnews outreach
Love your liver✅
Hepatology is hot ✅

https://t.co/h2t8OVi4Or

[Helle Lindholm Schnefeld @Helle_schne]

PhD defence by @CharlotteWERN

Why NAFLD?

‼️Steatosis in 1/3 of all adults
🆙Prevalence
🤷‍♀️Lack of NILTs for NASH
Tissue plasticity? @ATLAS_SDU

Publication 1: https://t.co/ISiLY90soW… #TREM2

Supervisors @AleksanderKrag @MMLauridsen
Opponents @marurinella @Filip_Knop

[Aleksander Krag @AleksanderKrag]

#NordicNASHOdense2023 in 3 days- April 20th

Join 200 colleagues F2F/online in Odense
Free: Still online availabilities

👉When to refer and how to follow-up?
👉What interventions can we offer?
👉Current best practice

https://t.co/kgCOZghfDo

[Aleksander Krag @AleksanderKrag]

Fatty liver disease ↗️

👉 Late diagnosis
👉 Healthcare pathways in #NAFLD?
👉Today Sunday we tried something different

➡️ Drop-in Fibroscan in T2D / BMI>30
👉Announced on FB and local media

➡️102 scanned

📣14% TE>9Kpa

😳 Most had never had a liver check

 #Livertwitter

[Aleksander Krag @AleksanderKrag]

👉What does the future hold for NASH patients?

Don’t miss out on this great opportunity, April 20th F2F in Odense or online.

👉🌟🌟🌟 FACULTY

[Camilla Dalby Hansen, MD, PhD @Camilla_Dalby]

Join our NORDIC NASH symposium for free🤩

April 20th💪

World leading experts with short, sharp and exiting presentations on the newest updates in NASH research!

Check out the full program: https://t.co/hoDkPJce2T

See you in Odense or online🤩 We can’t wait👏

[Mads Israelsen @IsraelsenMads]

GALA-RIF is out in Lancet Gas Hep

Rifaximin-α seems to prevent worsening of alcohol-related liver disease

What a culmination of 8 years committed team work 🙌😅❤️

https://t.co/uSDUQWnkgu

#livertwitter @LancetGastroHep @EricTopol

[Katrine Tholstrup Bech @Kat_Bech]

So proud to be a part of this amazing team 🙌🏼 @FLASH_OUH